The Fc tail of the anti-CD38 mAbs engage the C1q molecule and initiates the classical complement cascade, leading the deposition of C3b on MM cell surface inducing the CDC, the recognition by phagocytic cells and the production of the anaphylatoxins C3a and C5a (40, 45). This evidence concerns the gene C3 and Miyoshi myopathy.